Leading market players are investing heavily in research and development in order to expand their product lines, which will help the wound dressing market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, wound dressing industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the wound dressing industry to benefit clients and increase the market sector. In recent years, the wound dressing industry has offered some of the most significant advantages. Major players in the wound dressing market, including 3M (US),Smith & Nephew plc (UK), Integra LifeSciences Holdings Corporation (US), Mölnlycke Health Care AB (Sweden), ConvaTec Group plc (UK),Coloplast A/S (Denmark),Medline Industries, Inc. (US)., and others, are attempting to increase market demand by investing in research and development operations.
MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g. In July 2022, MolecuLight Inc., a manufacturer in point-of-care fluorescence imaging for the detection of wounds containing elevated bacterial loads, announced the publication of an independent, blind randomized controlled trial in Diabetes Care.
The publication reported that the 12-week wound healing rates (204%) in patients with diabetic foot ulcers who used a MolecuLight i:X device to visualize the presence of high bacterial burden in wounds were twice those who used standard-of-care alone.
Cork Medical is a Medical Device and Support Surface Manufacturer that specializes in designing and manufacturing innovative products for the treatment and prevention of wounds. The company products consist of Negative Pressure Wound Therapy (NPWT), Specialty Mattresses, Overlays, and Cushions. The Nisus NPWT pump launched in March of 2015 and is making a major impact in the Home Care, Long Term Care, and Acute Care settings. With careful engineering, state-of-the-art product design, and competitive pricing, demand for Cork Medical’s products continues to grow throughout the United States and globally.
In March 2022, Cork Medical, a global manufacturer of wound care technologies, announced a partnership with MedTech Solutions Group (MTSG), a company that focuses on international medical device commercialization needs. In this partnership, Cork Medical, MTSG is now managing Cork Medical's international Negative Pressure Wound Therapy (NPWT) business in all countries, except the United States.